An Australian research team have reportedly developed a new diabetes drug that could end one of the complications of the disease .
University of Melbourne researchers, and a research team at the St Vincent Hospital claimed that a new drug could prevent fibrosis, which is the build up of scarring on internal organs.
Fibrosis is untreatable, with no medication on the market for the drugs. The new drug, called FT-11 could be groundbreaking in preventing the disease. The drug will not prevent diabetes, but it could help to prevent complications such as heart disease and kidney disease.
Professor Darren Kelly reportedly commented: “It would be an enormous blockbuster drug with an initial market of around 2.0 billion dollars. We are hoping to delay or prevent those complications which would basically keep those patients off dialysis — which would have a huge benefit for their lifestyle. We know at the moment in rat studies that our compound inhibited the development of fibrosis, and the interesting thing in the future would be to see whether we can actually reverse fibrosis.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…